Ensign Group, Inc ENSG
We take great care to ensure that the data presented and summarized in this overview for ENSIGN GROUP, INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ENSG
View all-
Black Rock Inc. New York, NY9.02MShares$1.17 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.17MShares$797 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.5MShares$452 Million2.33% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.24MShares$290 Million0.06% of portfolio
-
State Street Corp Boston, MA2.1MShares$271 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.37MShares$176 Million0.01% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.35MShares$174 Million0.7% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.18MShares$153 Million0.04% of portfolio
-
Riverbridge Partners LLC1.13MShares$146 Million2.11% of portfolio
-
Baillie Gifford & CO985KShares$127 Million0.1% of portfolio
Latest Institutional Activity in ENSG
Top Purchases
Top Sells
About ENSG
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Insider Transactions at ENSG
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2025
|
Beverly B. Wittekind VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-0.29%
|
$14,224
$127.12 P/Share
|
|
Feb 14
2025
|
Daren Shaw Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.06%
|
$258,000
$129.66 P/Share
|
|
Feb 11
2025
|
Ann Scott Blouin Director |
SELL
Open market or private sale
|
Direct |
450
-2.07%
|
$57,600
$128.06 P/Share
|
|
Feb 10
2025
|
Christopher R. Christensen Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
5,023
+22.24%
|
$647,967
$129.23 P/Share
|
|
Feb 10
2025
|
Barry Port Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,154
+16.19%
|
$1,825,866
$129.23 P/Share
|
|
Feb 10
2025
|
Suzanne D. Snapper CFO |
BUY
Grant, award, or other acquisition
|
Direct |
12,252
+4.36%
|
$1,580,508
$129.23 P/Share
|
|
Feb 10
2025
|
Chad Keetch CIO, EVP and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,094
+7.57%
|
$1,044,126
$129.23 P/Share
|
|
Feb 10
2025
|
Spencer Burton President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,365
+15.39%
|
$1,337,085
$129.23 P/Share
|
|
Feb 05
2025
|
Christopher R. Christensen Executive Chairman |
SELL
Open market or private sale
|
Direct |
39,086
-45.22%
|
$5,784,728
$148.78 P/Share
|
|
Feb 05
2025
|
Christopher R. Christensen Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
39,086
+13.16%
|
$2,306,074
$59.94 P/Share
|
|
Feb 03
2025
|
Barry M Smith Director |
SELL
Open market or private sale
|
Direct |
700
-2.23%
|
$96,600
$138.48 P/Share
|
|
Jan 15
2025
|
Ann Scott Blouin Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+2.69%
|
-
|
|
Jan 15
2025
|
John O Agwunobi Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+7.57%
|
-
|
|
Jan 15
2025
|
Mark Vincent Parkinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+50.0%
|
-
|
|
Jan 15
2025
|
Swati Bargotra Abbott Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+3.36%
|
-
|
|
Jan 15
2025
|
Daren Shaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+2.07%
|
-
|
|
Jan 15
2025
|
Barry M Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+1.87%
|
-
|
|
Jan 02
2025
|
Barry M Smith Director |
SELL
Open market or private sale
|
Direct |
700
-2.22%
|
$93,100
$133.43 P/Share
|
|
Dec 10
2024
|
Suzanne D. Snapper CFO |
SELL
Bona fide gift
|
Direct |
640
-0.25%
|
-
|
|
Dec 02
2024
|
Swati Bargotra Abbott Director |
SELL
Bona fide gift
|
Direct |
35
-0.21%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 84.2K shares |
|---|---|
| Bona fide gift | 52.9K shares |
| Exercise of conversion of derivative security | 104K shares |
| Acquisition or disposition by will or laws | 7.22K shares |
| Open market or private purchase | 0 shares |
| Bona fide gift | 65K shares |
|---|---|
| Open market or private sale | 117K shares |
| Payment of exercise price or tax liability | 10.2K shares |